The activity of Spanish biotechnology companies generated approximately 0.9% of GDP in 2021 and invoiced more than 12,000 million, according to the Asebio 2021 Report: Towards sustainable and resilient growth, presented by the Spanish Association of Biocompanies. The group of biotechnology companies employed 121,755 people, which represents 0.7% of the total number of employed persons. Despite the pandemic and the conflict in Ukraine, the sector continues to grow for the sixth consecutive year.
Catalonia was at the head of these figures, leading in the number of companies dedicated to biotechnology with 209 companies that represent more than 24% in all of Spain. It also exceeded 45% of the average turnover with 26.6 million, followed by Aragón and Madrid.
The biotechnology industry added a private investment of more than 183 million in 41 operations in 2021, 20% more than in the previous year, and managed to increase its scientific production by 50%. According to Asebio, this factor and the percentage of researchers in the industry encouraged Spain to consolidate itself as the eighth world power in scientific matters.
